Hyperbaric oxygen therapy lowers blood pressure

In an eight week study performed on rats, hyperbaric oxygen therapy effectively improved blood pressure parameters and repressed hypertension. This clinical trial used a lower pressure protocol, using only 1.25 ATA. Though this phenomenon has been observed in clinical practice, this is the first study of its kind to demonstrate the not only the link between the two, but also the possible mechanisms that may be playing the key roles <view study>

Low pressure hyperbaric therapy shown effective in helping metabolic syndrome and reducing cardiac risks

A new study in the Journal of atherosclerosis and thrombosis published this year shows that low pressure hyperbaric oxygen therapy can be a very effective tool for helping those suffering from metabolic syndrome. Metabolic syndrome is a cluster of conditions — increased blood pressure, high blood sugar, excess body fat around the waist, and abnormal cholesterol or triglyceride levels — that occur together, increasing your risk of heart disease, stroke and diabetes. This study looked at only 1.25 ATA (low pressure hyperbarics) and found that this dosage was effective enough to produce a lowering of blood sugars, blood pressure, total cholesterol, and insulin. Many other positive benefits were noted <view study>

Hyperbaric Oxygen Therapy Improves Heart Function and Cardiac Performance

This study looked at the performance of the heart as they followed 31 patients, each undergoing a course of 60 hyperbaric sessions with the goal of improving cognitive performance. Of these 31 patients, 39% were diagnosed with heart disease, 94% suffered from high blood pressure, and 42% had diabetes mellitus. Most importantly, all 31 patients were screened to be asymptomatic, and did not have any symptoms of heart disease (representing the majority of the public). Researchers documented their results by using pre and post imaging of the heart through ultrasound (echocardiogram). The results were extremely favourble following the addition of 60 hyperbaric sessions; ejection fraction (EF) of the heart improved, Left ventricular end systolic volume decreased, Myocardial performance index [MPi] improved, Left ventricular [LV] global longitudinal strain increased, and apical rotation improved. This study gives hope for those individuals suffering from heart failure and systolic dysfunction and who need to improve their cardiac performance <view study>